Sepe, P.; Verzoni, E.; Miodini, P.; Claps, M.; Ratta, R.; Martinetti, A.; Mennitto, R.; Sottotetti, E.; Procopio, G.; Cappelletti, V.;
et al. Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience. Cancers 2019, 11, 980.
https://doi.org/10.3390/cancers11070980
AMA Style
Sepe P, Verzoni E, Miodini P, Claps M, Ratta R, Martinetti A, Mennitto R, Sottotetti E, Procopio G, Cappelletti V,
et al. Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience. Cancers. 2019; 11(7):980.
https://doi.org/10.3390/cancers11070980
Chicago/Turabian Style
Sepe, Pierangela, Elena Verzoni, Patrizia Miodini, Melanie Claps, Raffaele Ratta, Antonia Martinetti, Roberta Mennitto, Elisa Sottotetti, Giuseppe Procopio, Vera Cappelletti,
and et al. 2019. "Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience" Cancers 11, no. 7: 980.
https://doi.org/10.3390/cancers11070980
APA Style
Sepe, P., Verzoni, E., Miodini, P., Claps, M., Ratta, R., Martinetti, A., Mennitto, R., Sottotetti, E., Procopio, G., Cappelletti, V., & Daidone, M. G.
(2019). Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience. Cancers, 11(7), 980.
https://doi.org/10.3390/cancers11070980
